Insight Report: Potential Therapeutic Targets for Alzheimer’s | BioSpace
Nov 4 · 24 min read
What is the best way to prevent or even reverse Alzheimer’s disease?
The plot just thickened when and recently announced they will pursue FDA approval for aducanumab, the anti-amyloid antibody drug they previously predicted would not hit its primary endpoints in the global Phase 3 trials ENGAGE and EMERGE and the Phase 2 trial EVOLVE…


